Cargando…
Exforge(®) (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact
INTRODUCTION: Hypertension is an important risk factor for cardiovascular disease and its management requires improvement. New treatment strategies are needed. AIMS: This review analyses one of these strategies, which is the development of effective and safe combination therapy. Indeed, at least two...
Autores principales: | Krzesinski, Jean-Marie, Cohen, Eric P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899780/ https://www.ncbi.nlm.nih.gov/pubmed/20694060 |
Ejemplares similares
-
Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010) -
Simultaneous Determination of Amlodipine and Valsartan
por: Mohamed, Nashwah Gadallah
Publicado: (2011) -
Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension
por: Wang, Xiao-ou, et al.
Publicado: (2019) -
Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
por: Oh, Jin Kyung, et al.
Publicado: (2020) -
A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension
por: Ferdinand, Keith C., et al.
Publicado: (2013)